PT - JOURNAL ARTICLE AU - Dean J. Miller AU - John V. Capodilupo AU - Michele Lastella AU - Charli Sargent AU - Gregory D. Roach AU - Victoria H. Lee AU - Emily R. Capodilupo TI - Analyzing changes in respiratory rate to predict the risk of COVID-19 infection AID - 10.1101/2020.06.18.20131417 DP - 2020 Jan 01 TA - medRxiv PG - 2020.06.18.20131417 4099 - http://medrxiv.org/content/early/2020/06/19/2020.06.18.20131417.short 4100 - http://medrxiv.org/content/early/2020/06/19/2020.06.18.20131417.full AB - COVID-19, the disease caused by the SARS-CoV-2 virus, can cause shortness of breath, lung damage, and impaired respiratory function. Containing the virus has proven difficult, in large part due to its high transmissibility during the pre-symptomatic incubation. The study’s aim was to determine if changes in respiratory rate could serve as a leading indicator of SARS-CoV-2 infections. A total of 271 individuals (age = 37.3 ± 9.5, 190 male, 81 female) who experienced symptoms consistent with COVID-19 were included – 81 tested positive for SARS-CoV-2 and 190 tested negative; these 271 individuals collectively contributed 2672 samples (days) of data (1856 healthy days, 231 while infected with COVID-19 and 585 while infected with something other than COVID-19). To train a novel algorithm, individuals were segmented as follows; (1) a training dataset of individuals who tested positive for COVID-19 (n=57 people, 537 samples); (2) a validation dataset of individuals who tested positive for COVID-19 (n=24 people, 320 samples) ; (3) a validation dataset of individuals who tested negative for COVID-19 (n=190 people, 1815 samples). All data was extracted from the WHOOP system, which uses data from a wrist-worn strap to produce validated estimates of respiratory rate and other physiological measures. Using the training dataset, a model was developed to estimate the probability of SARS-CoV-2 infection based on changes in respiratory rate during night-time sleep. The model’s ability to identify COVID-positive individuals not used in training and robustness against COVID-negative individuals with similar symptoms were examined for a critical six-day period spanning the onset of symptoms. The model identified 20% of COVID-19 positive individuals in the validation dataset in the two days prior to symptom onset, and 80% of COVID-19 positive cases by the third day of symptoms.Competing Interest StatementThe authors of this manuscript have the following competing interests: Emily R. Capodilupo is a shareholder and employee of Whoop, Inc. John V. Capodilupo is a shareholder and employee of Whoop, Inc. Victoria H. Lee is an employee of Whoop, Inc. Whoop, Inc is sponsoring the Research Officership of Dean J. Miller. There are no other competing interests for the authors. Funding StatementThere was no specific funding for this study.Author DeclarationsI confirm all relevant ethical guidelines have been followed, and any necessary IRB and/or ethics committee approvals have been obtained.YesThe details of the IRB/oversight body that provided approval or exemption for the research described are given below:This study was approved by the Central Queensland University Human Research Ethics Committee.All necessary patient/participant consent has been obtained and the appropriate institutional forms have been archived.YesI understand that all clinical trials and any other prospective interventional studies must be registered with an ICMJE-approved registry, such as ClinicalTrials.gov. I confirm that any such study reported in the manuscript has been registered and the trial registration ID is provided (note: if posting a prospective study registered retrospectively, please provide a statement in the trial ID field explaining why the study was not registered in advance).YesI have followed all appropriate research reporting guidelines and uploaded the relevant EQUATOR Network research reporting checklist(s) and other pertinent material as supplementary files, if applicable.YesData cannot be shared publicly because of user privacy.